Respiratory Viruses Flashcards
Respiratory Viruses
Influenza virus
Rhinovirus
Coronavirus
Parainfluenza virus
Respiratory synctial virus
Metapneumovirus
Adenovirus (sometimes)
Virus families
- Picornaviridae (rhinovirus, coxsackie virus, echovirus, enterovirus)
- Coronaviridae (coronavirus, SARS-CoV)
- Orthomyxoviridae (Influenza A,B,C virus)
- Paramyxoviridae (Parainfluenza virus, respiratory synctial virus, metapneumovirus, measles virus)
Orthomyxovirus
Family:
Genus:
Individual Strain:
Subtypes:
Types:
Family: Orthomyxovirus
Genus: Influenza; Thogotovirus
Individual Strain: A/BAngkok/1/79(H3N2)
Subtypes: Based on hemagglutinin and neuramidase
Types: Based on matrix and nucleoprotein antigens
Antigenic Drift
Minor changes in either the hemagglutinin or neuramidase, or both
- Minor antigenic variations reslut from mutations in hemagglutinin and neuraminidase genes
- The hemagglutinin mutations are primarily found in the four antibody combining sites in the hemagglutinin protein
Major antigenic shift
Occurs infrequently, either hemagglutinin alone or neuraminidase as well. Occurs as a result of gene reassortment between a human and animal strain
Influenza Pathogenesis
- Influenza is an acute respiratory disease
- infects ciliated epithelial cells lining the upper respiratory tract, trachea, bronchi
- Virus replication - destruciton of respiratory epithelium
- Cell damage also due to virus activated CTL
- Viremia - not a major role
Acute influenza infection in adults - symptoms
Rapid onset of fever, malaise, myalgia sore throat and nonproductive cough
Acute influenza infection in children
Acute disease similar to that in adults but with higher fever, GI tract symptoms, otitis media, myositis
Complications of influenza virus infection
Primary viral pneumonia
Secondary bacterial pneumonia
Myositis and cardiac involvement
Neurologic syndromes
Influenza diagnosis
- Clinical signs and epidemiology
- Lab diagnosis
- Rapid antigen capture detects nucleoprotein (15 min)
- rt-PCR
- Hemagglutination/ Serology
- Virus isolation
- Immunofluorescent techniques
Replication and Spread of influenza (7 steps)
- Binding
- Coating/Fusing
- Transcription
- Proteins synthesized
- Replication
- Assembly
- Budding
What is the influenza virus cellular receptor?
Sialic acid
How does the viral membrane fuse with the vesicular membrane inside the cell?
Lowers the pH which triggers fusion and release of contents
Prevention and control of influenza: Immunization
- Formalin inactivated - mixture of prevalent antigenic types
- Attenuated infectious viruses - intranasal administration
- Experimental - DNA vaccines - reverse transcriptase
Prevention and control of influenza: Chemotherapy
- Amantadine and rimantadine - inhibit uncoating by blocking M2 protein
- Ribavirin - inhibits syntehsis of viral RNA
- Zanamivir and Oseltamivir (Tamiflu) neuraminidase inhibitors
Influenza is usually treated with a _______ vaccine
Trivalent
Rhinovirus (characteristics)
- Causes 50% of common colds
- >150 serotypes identified
- Temperature sensitive - grows better at 33º than 37º
- Secretory IgA is most important in limiting reinfection
- Transmission by respiratory secretions
Rhinovirus symptoms
- Headache
- Cough
- Sore throat
- Mucus
- Nasal discharge
All due to inflammatory response
Rhinovirus prevention and control
No effective prevention and control measures to date
- Experimental
- Viral protease inhibitors (Ruprintrivir)
- WIN compounds - block uncoating by inserting in virus surface pore
Rhinoviruses are transmitted via _______
fomites
Coronaviruses (characteristics)
Cause common colds - watery eyes, sneezing, nasal congestion, sore throat
Disesae limited to upper respiratory tract, infects epithelial cells
No vaccine available
Coronavirus Outbreaks
- 2002-2003: SARS outbreak caused by SARS-CoV
- 2012 - acute pneumonia and renal failure MERS-CoV originally named hCoV EMC
Coronavirus - SARS
Fatality Rate:
Transmission:
Source:
Vaccines:
Sudden acute respiratory syndrome
Fatality Rate: 10%
Transmission: Mainly by face-to-face contact; virus in respiratory secretions and feces; not highly contagious
Source: Bats, and other animals sold in markets in China
Vaccines: none currently available
MERS-CoV
Difference from SARS:
First Reported:
Origin:
Cases to date:
Middle East Respiratory Syndrome
Difference from SARS:
- Uses a different cellular receptor
- Does not readily pass from person to person
First Reported: September 2012 (May 2014-US)
Origin: Middle East (nosocomial infections documented)
Cases to date: 400